Innovating Works

AUDION

Desconocido
REGAIN: REgeneration of inner ear hair cells with GAmma secretase INhibitors to regain hearing in patients w... AUDION THERAPEUTICS BV tramitó un H2020: H2020-PHC-2014-2015 Hearing loss is a chronic non-communicable disease disabling over 328 million adults, and 32 million children worldwide. Sensorineural heari...
2015-04-07 - 2019-10-31 | Financiado
OTOSTEM: Human stem cell applications for the treatment of hearing loss AUDION THERAPEUTICS BV participó en un FP7: Hearing impairment is the most frequent human sensory deficit and is mainly caused by the irreversible loss of neurosensory cells in the coc...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.